190 related articles for article (PubMed ID: 28012286)
41. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.
Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S
Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439
[TBL] [Abstract][Full Text] [Related]
43. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.
Kato M; Goto Y; Matsushita R; Kurozumi A; Fukumoto I; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Int J Oncol; 2015 Aug; 47(2):710-8. PubMed ID: 26063484
[TBL] [Abstract][Full Text] [Related]
45. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
46. Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas.
Wei D; Yu Z; Cheng Y; Jiawei H; Jian G; Hua G; Guilan D
Mol Cell Endocrinol; 2021 Jan; 520():111083. PubMed ID: 33246030
[TBL] [Abstract][Full Text] [Related]
47. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.
Declercq J; Van Dyck F; Braem CV; Van Valckenborgh IC; Voz M; Wassef M; Schoonjans L; Van Damme B; Fiette L; Van de Ven WJ
Cancer Res; 2005 Jun; 65(11):4544-53. PubMed ID: 15930271
[TBL] [Abstract][Full Text] [Related]
48. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.
Yu G; Li C; Xie W; Wang Z; Gao H; Cao L; Hao L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1140-1148. PubMed ID: 28656268
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Khan MM; Zivkovic V; Bálint K; Korbonits M; Rácz K; Patócs A
J Clin Endocrinol Metab; 2010 Oct; 95(10):E181-91. PubMed ID: 20668041
[TBL] [Abstract][Full Text] [Related]
51. MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.
Sun YP; Lu F; Han XY; Ji M; Zhou Y; Zhang AM; Wang HC; Ma DX; Ji CY
Oncotarget; 2016 May; 7(18):25276-90. PubMed ID: 27013583
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2.
Zhou H; Guo W; Zhao Y; Wang Y; Zha R; Ding J; Liang L; Hu J; Shen H; Chen Z; Yin B; Ma B
Int J Oncol; 2014 Jun; 44(6):2050-8. PubMed ID: 24682444
[TBL] [Abstract][Full Text] [Related]
53. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.
Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z
Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035
[TBL] [Abstract][Full Text] [Related]
54. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
Lu J; Song G; Tang Q; Yin J; Zou C; Zhao Z; Xie X; Xu H; Huang G; Wang J; Lee DF; Khokha R; Yang H; Shen J
Oncogene; 2017 Jan; 36(2):231-241. PubMed ID: 27270422
[TBL] [Abstract][Full Text] [Related]
55. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
56. microRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA.
Konishi H; Fujiya M; Ueno N; Moriichi K; Sasajima J; Ikuta K; Tanabe H; Tanaka H; Kohgo Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):847-52. PubMed ID: 26494299
[TBL] [Abstract][Full Text] [Related]
57. Correlation between SPARC (Osteonectin) expression with immunophenotypical and invasion characteristics of pituitary adenomas.
Onoz M; Basaran R; Gucluer B; Isik N; Kaner T; Sav A; Elmaci I
APMIS; 2015 Mar; 123(3):199-204. PubMed ID: 25556322
[TBL] [Abstract][Full Text] [Related]
58. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
59. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
[TBL] [Abstract][Full Text] [Related]
60. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness.
Takino H; Herman V; Weiss M; Melmed S
J Clin Endocrinol Metab; 1995 May; 80(5):1733-8. PubMed ID: 7745027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
